Steris | STE - Umsatzkosten

Aktienkurs
212.65
Täglich Wechseln
-7.10 -3.23%
Monatlich
-3.07%
Jährlich
-5.38%
Q2 Prognose
217.05




Umsatzkosten Veränderung Datum
3M USD 3.57B 501M 2026-03
Accuray USD 116.17M 14.63M 2024-12
Avanos Medical USD 94.9M 3.1M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.83B 8M 2026-03
CONMED USD 154.91M 16.9M 2025-12
Cooper Companies USD 376.8M 87.4M 2025-12
Dexcom USD 466.9M 11M 2025-12
Ecolab USD 2.28B 64.4M 2026-03
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Fortive USD 413.6M 35.7M 2025-12
Getinge SEK 6.02B 1.7B 2024-12
Globus Medical USD 290.47M 8.09M 2025-12
Haemonetics USD 136.58M 4.01M 2025-12
Idexx Laboratories USD 432.46M 10.58M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
Intuitive Surgical USD 940.3M 21.6M 2026-03
J&J USD 8.07B 103M 2026-03
Masimo USD 165.2M 24.3M 2025-12
Olympus JPY 96.15B 9.61B 2025-12
Orthofix International USD 66.63M 6.4M 2025-12
Owens Minor USD 436.92M 32.62M 2025-12
ResMed USD 555.85M 29.13M 2025-12
Steris USD 840.7M 26.3M 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03